Methyl 2-fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoate, 95.0%, 1g

2',4'-Bis(trifluoromethyl)acetophenone, 98.0%, 250mg

2-OXA-8-AZASPIRO[4.5]DECANE HEMIOXALATE, 95.0%, 1g

6-Chloro-4-nitro-1H-indazole, 95.0%, 1g

Center telescope for phasing for bScope non IOS models (finitely corrected objectives)

5-Cyanopyrimidine, 95.0%, 1g

8-Bromo-5-nitroquinoline, 95.0%, 10g

1-(2-CHLOROPHENYL)CYCLOBUTANEMETHANAMINE, 95%, 100mg

3-[(4-Chlorophenyl)methoxy]-N-[(1S)-1-phenylethyl]thiophene-2-carboxamide, 98%, 50mg

6-Morpholinopicolinic acid, 95.0%, 10g

2-Pyrrolidin-1-yl-propionic acid, 95.0%, 5g

1,2,3,4-Tetrachlorobenzene>96.0%(GC)25g

Methyl 2,4-bis(trifluoromethyl)benzoate, 97%, 100g